Valeant says it's on road to recovery despite cutting forecasts for 2015

Valeant Pharmaceuticals says it's on the road to recovery after taking big financial and PR hits from its association with a controversial U.S.

See Full Article

mail-order pharmacy.

The Quebec-based company expects its revenues and adjusted earnings will increase by double digits in 2016 and its battered share price will once again reflect the fundamentals of its business.

"We have been through a lot," CEO Michael Pearson told investors during a four-hour webcast.

Pearson said he was "pissed" at the "false" allegations about the company from a short seller that drove its share price collapse and prompted some calls for him to be replaced.

"If the board wants to fire me they are welcome to fire me but until they do we're going to get through this thing."

Valeant said the October split from specialty pharmaceutical partner Philidor Rx Services caused a big short-term disruption to its business that will reduce its expectations for the fourth quarter and 2015 as a whole.

However, Pearson said a new distribution deal with a prominent U.S. drugstore chain, Walgreens, is a better arrangement than the one with Philidor, a low-profile company that distributed specialty drugs for Valeant.

Despite cutting prices, Valeant expects it will make more money by gaining access to the 8,000-store network of the largest American pharmacy retailer.

"The opportunity for volume growth is huge," he told analysts.

Pearson said Walgreens was "courageous" for partnering with Valeant given the negative attention heaped on the company in the last few months.

"(But) we both fundamentally believe that this is going to change the industry, it's going to create enormous value for both our shareholders."

Valeant conceded the company, which has been accused of price-gouging for some of its products, has altered its strategy to pursue volume growth by lowering prices and reducing costs.

The deal with Walgreens is forecast to deliver up to US$600 million in annual savings to the U.S. health-care system starting next year after Valeant agreed to cut the prices of several of its drugs as part of the distribution agreement.

Alex Arfaei of BMO Capital Markets said the 2016 revenue guidance of US$12.5 billion to US$12.7 billion is in line with forecasts, but targeted earnings are weaker than predicted.

That "indicates to us that the increase in expected volume from the Walgreens agreement is not enough to offset the loss of more profitable products from the specialty pharmacy business at higher prices, at least in the near term," he wrote in a report.

The Montreal-area company's previously obscure relationship with Philidor and its pricing policies, which are under investigation by U.S. authorities, have contributed to a major decline in the company's stock.

Shares were up nearly eight per cent to $161.26 in Wednesday afternoon trading on the Toronto Stock Exchange.

That's compared to the 52-week low of $92.65 and the $347.84 high in August before its troubles began.

The company faces several U.S. investigations, including at a committee of the U.S. House of Representatives that will be holding a hearing in the new year on increasing prices for medication.

A high-ranking U.S. politician released a letter sent to Valeant that accuses the firm of failing to disclose information as requested and obstructing the congressional investigation.

"Your refusal to provide any documents or witnesses is obstructing this congressional investigation and preventing a full understanding of your company's suspect actions," wrote Elijah Cummings, the committee's ranking Democrat.


Latest Economic News

  • Toronto lawyer Galati files constitutional challenge against EU trade deal

    Economic CTV News
    OTTAWA -- The Toronto lawyer who successfully challenged the previous Conservative government over one of its Supreme Court judge nominees is setting his sights on a new target: Canada's free trade deal with the European Union. Source
  • Federal deficit likely to come in smaller than predicted in budget: PBO

    Economic CBC News
    The federal government is on track to post smaller deficits in the coming years than the Liberals are currently forecasting, Canada's non-partisan parliamentary budget watchdog said on Monday. The Parliamentary Budget Officer said in a report Monday it expects Ottawa to post a deficit of just over $22 billion this year. Source
  • Quebec carbon market not changing behaviours so far, but experts are hopeful

    Economic CTV News
    OTTAWA -- As politicians across the country worry about the consequences of a national carbon tax on family incomes, many experts say the much-touted carbon market in Quebec has so far had little effect on changing citizens' habits. Source
  • Jared Fogle's ex-wife sues Subway

    Economic CTV News
    NOBLESVILLE, Ind. -- The ex-wife of former Subway pitchman Jared Fogle is suing the restaurant chain for damages, saying the company received three reports indicating his sexual interest in children but failed to take proper action and continued promoting him as their spokesman. Source
  • Lexus, Toyota, Buick top Consumer Reports' reliability list

    Economic CBC News
    Lexus, Toyota and Buick are the most reliable brands in Consumer Reports' latest survey, a reward for their conservative approach to new technology. It's the fourth straight year that Lexus came in first and Toyota came in second. Source
  • Capital Power pushes back Genesee 4 and 5 power plant

    Economic CTV News
    CALGARY - Capital Power has once again delayed a final go-ahead on its new natural gas-fired power plant because of continued uncertainty about Alberta's coal phase-out and power market. The proposed $1.4-billion Genesee 4 and 5 power plant, half-owned by utility Enmax Corp. Source
  • Trump Hotels ditches Trump name for new brand

    Economic CBC News
    The Trump name is likely to be everywhere for the next 14 days, with one notable exception: it won't be associated with any new hotels owned by the Republican presidential candidate's eponymous company. Trump Hotels will use the brand name Scion for new projects targeted at young, urban travellers, the hotel chain said in a press release. Source
  • From eponymous to anonymous: Trump Hotels ditches Trump name for new youth brand

    Economic CBC News
    The Trump name is likely to be everywhere for the next 14 days, with one notable exception: it won't be associated with any new hotels owned by the Republican presidential candidate's eponymous company. Trump Hotels will use the brand name Scion for new projects targeted at young, urban travellers, the hotel chain said in a press release. Source
  • Authorities lack 'manpower' to remove Dakota Access oil pipeline protest camp

    Economic CTV News
    BISMARCK, N.D. -- Authorities say they won't immediately remove the Dakota Access oil pipeline protesters who set up a camp on private land along the pipeline route in North Dakota. Morton County Sheriff's Office spokeswoman Donnell Preskey says authorities "don't have the manpower" currently to remove the more than 100 protesters who are trespassing. Source
  • Bank of Canada and Ottawa renew 2% inflation target deal

    Economic Toronto Sun
    OTTAWA — The Bank of Canada and the federal government said Monday they have renewed their inflation target agreement for another five years in an effort to foster price stability and sustainable economic growth. The target will continue to be two per cent — the midpoint of a range of one to three per cent that the central bank deems acceptable. Source